• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服牛磺熊去氧胆酸和/或肠道益生菌对胆囊结石患者血清生化指标及胆汁成分的影响。

Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis.

作者信息

Gao Fan, Guan Dongyao, Wang Gangliang, Zhang Luting, He Junmin, Lv Wenqiao, Zhang Xiaofeng, Tao Weifeng, Dai YeFeng, Xu Song, Chen Yeqi, Lu Bin

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Shangyu People's Hospital of Shaoxing, Shaoxing, China.

出版信息

Front Pharmacol. 2022 Oct 24;13:882764. doi: 10.3389/fphar.2022.882764. eCollection 2022.

DOI:10.3389/fphar.2022.882764
PMID:36353477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9638003/
Abstract

In recent years, gallstones have become a major condition affecting people's health. Cholecystectomy remains an effective treatment method, but it has large risk factors. It is well known that the hepatoenteric axis plays a key role in gallstone formation, and it is gradually becoming a research focus. Cholesterol homeostasis can be regulated by the liver and intestinal tract in our bodies, and intestinal flora can regulate the digestion and absorption of cholesterol. These two factors are closely related to the formation of gallstones. To investigate the effects of tauroursodeoxycholic acid (TUDCA) and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis. For this study, 96 patients with cholecystolithiasis were recruited at our hospital. The patients were randomly divided into four groups according to a random number table: group Ⅰ (TUDCA, 24 cases), group Ⅱ (intestinal probiotics, 24 cases), group Ⅲ (TUDCA and intestinal probiotics, 24 cases) and group Ⅳ (control group, 24 cases). All patients underwent laparoscopic gallbladder-preserving lithotomy or laparoscopic cholecystectomy. Bile samples were identified and extracted during the operation. The results revealed that the levels of serum total bile acid (TBA), serum total cholesterol (TCHOL) and serum triglyceride in groups I, II and III before and after the intervention were statistically significant ( < 0.05). There were significant differences in serum low-density lipoprotein cholesterol (LDL-C) between groups I and II before and after the intervention ( < 0.05), but the serum LDL-C level in group Ⅲ before and after the intervention was similar ( > 0.05). Regarding bile, TBA levels demonstrated no significant difference between groups I and III ( > 0.05), and the differences between the other two groups were statistically significant ( < 0.05). No significant difference was identified in phospholipid and TCHOL levels between groups I and Ⅲ ( > 0.05), and the differences between the other two groups were statistically significant ( < 0.05). There were significant differences in the levels of free Ca, pH value and glycoprotein in bile among the four groups ( < 0.05). The levels of cholic acid, chenodeoxycholic acid and deoxycholic acid in bile were significantly different among the four groups ( < 0.05). The level of lithocholic acid (LCA) in groups Ⅱ and Ⅲ was similar, as was the level of LCA in groups I and ⅠV, but the difference in level between the other two groups was statistically significant ( < 0.05). The combination of TUDCA and intestinal probiotics did not enhance the effect of either treatment. The use of intestinal probiotics alone can maximise the reverse development of bile composition in patients with cholecystolithiasis compared with TUDCA alone and a combination of TUDCA and intestinal probiotics, thereby reducing gallstone formation.

摘要

近年来,胆结石已成为影响人们健康的主要病症。胆囊切除术仍然是一种有效的治疗方法,但存在较大风险因素。众所周知,肝肠轴在胆结石形成中起关键作用,并且逐渐成为研究热点。我们体内的肝脏和肠道可调节胆固醇稳态,而肠道菌群可调节胆固醇的消化和吸收。这两个因素与胆结石的形成密切相关。为研究牛磺熊去氧胆酸(TUDCA)和/或肠道益生菌对胆囊结石病患者血清生化指标及胆汁成分的影响。本研究在我院招募了96例胆囊结石病患者。根据随机数字表将患者随机分为四组:Ⅰ组(TUDCA组,24例)、Ⅱ组(肠道益生菌组;24例)、Ⅲ组(TUDCA与肠道益生菌联合组,24例)和Ⅳ组(对照组,24例)。所有患者均接受了腹腔镜保胆取石术或腹腔镜胆囊切除术。术中对胆汁样本进行识别和提取。结果显示,Ⅰ组、Ⅱ组和Ⅲ组干预前后血清总胆汁酸(TBA)、血清总胆固醇(TCHOL)和血清甘油三酯水平差异有统计学意义(P<0.05)。Ⅰ组和Ⅱ组干预前后血清低密度脂蛋白胆固醇(LDL-C)水平差异有统计学意义(P<0.05),但Ⅲ组干预前后血清LDL-C水平相似(P>0.05)。在胆汁方面,Ⅰ组和Ⅲ组TBA水平差异无统计学意义(P>0.05),其他两组间差异有统计学意义(P<0.05)。Ⅰ组和Ⅲ组磷脂及TCHOL水平差异无统计学意义(P>0.05),其他两组间差异有统计学意义(P<0.05)。四组胆汁中游离钙、pH值和糖蛋白水平差异有统计学意义(P<0.05)。四组胆汁中胆酸、鹅去氧胆酸和脱氧胆酸水平差异有统计学意义(P<0.05)。Ⅱ组和Ⅲ组石胆酸(LCA)水平相似,Ⅰ组和Ⅳ组LCA水平相似,但其他两组间水平差异有统计学意义(P<0.05)。TUDCA与肠道益生菌联合使用并未增强任何一种治疗的效果。与单独使用TUDCA以及TUDCA与肠道益生菌联合使用相比,单独使用肠道益生菌可使胆囊结石病患者胆汁成分的逆向变化最大化,从而减少胆结石形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9638003/5092d895377d/fphar-13-882764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9638003/0d900b382558/fphar-13-882764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9638003/0dd4026982d0/fphar-13-882764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9638003/5092d895377d/fphar-13-882764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9638003/0d900b382558/fphar-13-882764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9638003/0dd4026982d0/fphar-13-882764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9638003/5092d895377d/fphar-13-882764-g003.jpg

相似文献

1
Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis.口服牛磺熊去氧胆酸和/或肠道益生菌对胆囊结石患者血清生化指标及胆汁成分的影响。
Front Pharmacol. 2022 Oct 24;13:882764. doi: 10.3389/fphar.2022.882764. eCollection 2022.
2
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation.牛磺熊去氧胆酸(TUDCA)和肠道微生物群对小鼠胆囊结石形成的影响。
Ann Hepatol. 2021 Jul-Aug;23:100289. doi: 10.1016/j.aohep.2020.100289. Epub 2020 Nov 18.
3
Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.胆固醇结石和色素结石患者以及无结石受试者的胆汁脂质成分:脱氧胆酸对胆固醇结石的形成无作用。
Eur J Clin Invest. 2000 Dec;30(12):1099-106. doi: 10.1046/j.1365-2362.2000.00740.x.
4
The value of bile acid spectrum in the evaluation of hepatic injury in children with infectious mononucleosis caused by Epstein Barr virus infection.胆汁酸谱在评估由爱泼斯坦-巴尔病毒感染引起的传染性单核细胞增多症患儿肝损伤中的价值。
Front Pediatr. 2023 Mar 21;11:1109762. doi: 10.3389/fped.2023.1109762. eCollection 2023.
5
Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.人类肝脏3-羟基-3-甲基戊二酰辅酶A还原酶活性及胆汁脂质成分:与胆固醇结石病的关系以及胆酸和鹅去氧胆酸治疗的效果
J Lipid Res. 1981 Mar;22(3):410-22.
6
Serum and bile lipid levels in patients with and without gallstones.有胆结石和无胆结石患者的血清及胆汁脂质水平。
J Gastroenterol. 1996 Dec;31(6):823-7. doi: 10.1007/BF02358609.
7
High Levels of Serum Triglyceride, Low-density Lipoprotein Cholesterol, Total Bile Acid, and Total Bilirubin are Risk Factors for Gallstones.血清甘油三酯、低密度脂蛋白胆固醇、总胆汁酸和总胆红素水平升高是胆囊结石的危险因素。
Clin Lab. 2021 Aug 1;67(8). doi: 10.7754/Clin.Lab.2021.201228.
8
Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.小肠蠕动迟缓与胆固醇结石患者胆汁中脱氧胆酸增加有关。
Am J Gastroenterol. 1999 Sep;94(9):2453-9. doi: 10.1111/j.1572-0241.1999.01375.x.
9
[Correlation of retinol binding protein 4 with 
metabolic indexes of glucose and 
lipid, bile cholesterol saturation index].视黄醇结合蛋白4与糖脂代谢指标、胆汁胆固醇饱和指数的相关性
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Jun;40(6):657-65. doi: 10.11817/j.issn.1672-7347.2015.06.014.
10
Triglycerides and gallstone formation.甘油三酯与胆石形成。
Clin Chim Acta. 2010 Nov 11;411(21-22):1625-31. doi: 10.1016/j.cca.2010.08.003. Epub 2010 Aug 10.

引用本文的文献

1
Polydatin prevents cholesterol gallstone formation by regulating cholesterol metabolism via PPAR-γ signaling.白藜芦醇苷通过PPAR-γ信号通路调节胆固醇代谢来预防胆固醇性胆结石的形成。
Open Life Sci. 2025 Aug 1;20(1):20221009. doi: 10.1515/biol-2022-1009. eCollection 2025.
2
Association between hereditary spherocytosis and gallstone disease: Pathophysiology, diagnosis, and management.遗传性球形红细胞增多症与胆结石病的关联:病理生理学、诊断及管理
World J Gastrointest Surg. 2025 Jul 27;17(7):105033. doi: 10.4240/wjgs.v17.i7.105033.
3
Research progress in the treatment of gallstones with laparoscopic and endoscopic surgery: a narrative review.

本文引用的文献

1
Changes and Correlations of the Intestinal Flora and Liver Metabolite Profiles in Mice With Gallstones.胆结石小鼠肠道菌群与肝脏代谢物谱的变化及相关性
Front Physiol. 2021 Aug 19;12:716654. doi: 10.3389/fphys.2021.716654. eCollection 2021.
2
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation.牛磺熊去氧胆酸(TUDCA)和肠道微生物群对小鼠胆囊结石形成的影响。
Ann Hepatol. 2021 Jul-Aug;23:100289. doi: 10.1016/j.aohep.2020.100289. Epub 2020 Nov 18.
3
Changes in plasma bile acids are associated with gallbladder stones and polyps.
腹腔镜与内镜手术治疗胆结石的研究进展:一项叙述性综述
BMC Surg. 2025 May 29;25(1):238. doi: 10.1186/s12893-025-02977-8.
4
The Anti-Inflammatory and Curative Exponent of Probiotics: A Comprehensive and Authentic Ingredient for the Sustained Functioning of Major Human Organs.益生菌的抗炎和治疗功效:主要人体器官持续功能的综合和纯正成分。
Nutrients. 2024 Feb 16;16(4):546. doi: 10.3390/nu16040546.
血浆胆汁酸的变化与胆囊结石和息肉有关。
BMC Gastroenterol. 2020 Oct 31;20(1):363. doi: 10.1186/s12876-020-01512-8.
4
Gallstone Disease and Microbiome.胆结石病与微生物群
Microorganisms. 2020 Jun 2;8(6):835. doi: 10.3390/microorganisms8060835.
5
Mechanisms and regulation of cholesterol homeostasis.胆固醇稳态的机制和调节。
Nat Rev Mol Cell Biol. 2020 Apr;21(4):225-245. doi: 10.1038/s41580-019-0190-7. Epub 2019 Dec 17.
6
The ' lifestyle' of bile acid 7α-dehydroxylating bacteria: comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice.胆汁酸 7α-脱羟菌的“生活方式”:无菌小鼠中特定微生物群落的比较基因组学、宏转录组学和胆汁酸代谢组学分析。
Gut Microbes. 2020 May 3;11(3):381-404. doi: 10.1080/19490976.2019.1618173. Epub 2019 Jun 9.
7
Ursodeoxycholic acid accelerates bile acid enterohepatic circulation.熊去氧胆酸加速胆汁酸的肝胆肠循环。
Br J Pharmacol. 2019 Aug;176(16):2848-2863. doi: 10.1111/bph.14705. Epub 2019 Jul 6.
8
Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome.基于全球人类肠道微生物组的细菌胆汁盐水解酶(BSH)基因的分类分布特征和种群模式。
Microbiome. 2019 Jan 23;7(1):9. doi: 10.1186/s40168-019-0628-3.
9
Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.肠道微生物群与胆汁酸失调在非酒精性脂肪性肝病发病机制中的相互作用及益生菌的潜在治疗意义。
J Cell Biochem. 2019 Mar;120(3):2713-2720. doi: 10.1002/jcb.27635. Epub 2018 Nov 15.
10
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.肠道微生物群和肠道 FXR 介导二甲双胍的临床获益。
Nat Med. 2018 Dec;24(12):1919-1929. doi: 10.1038/s41591-018-0222-4. Epub 2018 Nov 5.